Is Amyris, Inc. a good investment? Amyris, Inc. (AMRS) is currently trading at 0.0500 USD.
No, it does not currently pay a dividend.
Amyris, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
| Split Date | Split Ratio to 1 |
|---|---|
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
| June 6, 2017 | 0.070000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion